Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Parasite Epigenetics: Targeted Drug Development. Support to write 2nd stage FP7 application.

Reference number
Coordinator iNovacia AB
Funding from Vinnova SEK 72 000
Project duration December 2012 - February 2013
Status Completed

Last updated 25 November 2019

Reference number 2012-04612

Page statistics